AbbVie scoops the pool

Posted 21 October 2021 AM

AbbVie has scooped the pool, winning first place in seven out of eight categories relating to the pharma industry's response to COVID-19 and overall corporate reputation, according to a new survey of autoimmune disease patient groups.

The company was pipped at the post in just one category - overall corporate reputation as voted by inflammatory bowel disease (IBD) patient groups with Janssen taking out first place and Takeda coming in second, leaving AbbVie with a bronze.

To see the whole article, please login